Furthermore, we demonstrated the synergistic effect of ACOT7 depletion and treatment with either IR or Doxo on cancer cell proliferation, suggesting ACOT7 might be a novel target for anti-cancer therapy. The gene discussed is ACOT7; the disease is cancer.